U.S. pharmaceutical company Eli Lilly announced on the 25th of last month (local time) interim results from Phase 1 clinical ...

An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...

One company dominates with an approved therapy, while the other bets on in vivo innovation. See how their financials and risk ...

Eli Lilly said Monday that a high dose of its gene-editing therapy reduced cholesterol levels by 62% in participants in a clinical trial.

Early CRISPR-based cholesterol therapy shows striking LDL reduction, but experts warn that safety, durability and off-target ...

Molecular clocks that can provide accurate estimates of both molecular age and lifespan across multiple mammalian species and ...

Researchers developed PRINCE, a small-molecule-controlled CRISPR system enabling precise, long-term regulation of gene editing.

A powerful molecular clock calibrated using data on gene activity from thousands of individuals can predicts biological ...

Editing your genes to eliminate bad cholesterol and a new discovery that could change the playbook for Alzheimer's. Here are ...

Pancreatitis is a complex inflammatory disease driven by both genetic and environmental factors. It poses substantial ...

What Is the MTHFR Gene Mutation? The MTHFR gene mutation is a variation in the MTHFR gene. This gene normally tells your body how to make the MTHFR protein. You need this protein to process folate, ...